未知股票 ONCS 深 沪
已收盘
--
0.000
NaN.00%
华盛通- 最 高--
- 今 开--
- 成交量 --
- 最 低 --
- 昨 收 --
- 总市值 0
- 52周最高 --
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 --
- 委 比 0.00%
- 总股本 596.27万
- 历史最高 --
- 量 比 0
- 振 幅 NaN.00%
- 历史最低 --
- 每 手 1
- 风险率 6.23%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多OncoSec Medical Files Voluntary Petition For Relief Under Bankruptcy
The Company’s sole subsidiary, OncoSec Medical Australia Pty, Ltd., expects to liquidate and wind down operations under Australian law pursuant to a Creditors’ Voluntary Liquidation.
2023-06-15 05:28
OncoSec Announces $1.33 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
EWING, N.J. and SAN DIEGO, May 16, 2023 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ: ONCS) (the "Company" or "OncoSec"), a clinical-stage biotechnology company developing intratumor...
2023-05-17 01:29
OncoSec Medical（纳斯达克股票代码：ONCS）股价跌破200日移动平均线5.70美元
OncoSec Medical Incorporated (NASDAQ:ONCS – Get Rating)'s share price passed be...
2023-03-24 15:33
OncoSec Medical Incorporated（纳斯达克股票代码：ONCS）12月空头利率下降60.2％
OncoSec Medical Incorporated (NASDAQ:ONCS – Get Rating) saw a large decline in ...
2023-01-19 06:51
斯托克新闻网启动对OncoSec Medical(纳斯达克：oncs)的报道
Analysts at StockNews.com started coverage on shares of OncoSec Medical (NASDAQ...
2023-01-08 16:32
肿瘤科医疗公司(纳斯达克：ONCS)获得斯托克新闻网分析师的卖出评级
Stock analysts at StockNews.com assumed coverage on shares of OncoSec Medical (...
2022-12-31 16:52
OncoSec Medical（纳斯达克股票代码：ONCS）现在由StockNews.com的分析师报道
StockNews.com began coverage on shares of OncoSec Medical (NASDAQ:ONCS – Get Ra...
2022-12-19 16:01
OncoSec Medical（纳斯达克股票代码：ONCS）的报道始于 StockNews
Investment analysts at StockNews.com assumed coverage on shares of OncoSec Medi...
2022-12-15 17:02
OncoSec Medical（纳斯达克股票代码：ONCS）获得StockNews.com分析师的卖出评级
StockNews.com started coverage on shares of OncoSec Medical (NASDAQ:ONCS – Get ...
2022-12-10 18:52
Humanigen（纳斯达克股票代码：HGEN）和 OncoSec Medical（纳斯达克股票代码：ONCS）财务比较
Humanigen (NASDAQ:HGEN – Get Rating) and OncoSec Medical (NASDAQ:ONCS – Get Rat...
2022-12-09 14:33
